NCT03079323View on ClinicalTrials.gov

Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

February 6, 2017

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions
Prostate Cancer
Interventions
RADIATION

PART-trial

Elective radiation to the para-aortic lymph nodes 45 Gy / 1.8 Gy

Trial Locations (1)

3000

RECRUITING

UZ Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT03079323 - Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer | Biotech Hunter | Biotech Hunter